Veeva Systems has announced that leaders from AstraZeneca, Bristol Myers Squibb, Grünenthal, Novo, Roche, and UCB are among those who will share strategies for driving commercial and medical excellence at
Antoine Kabre, electrical & controls engineering manager at PSB Industries, shares how historical operating data can turn a shutdown alarm into a starting point for understanding equipment behaviour, identifying recurring problems.
Pharmaceutical manufacturers face constant pressure to increase productivity while maintaining the quality, consistency and traceability demanded in highly regulated production environments. Beth Ragdale, Beckhoff UK & Ireland, discusses.
David Garratt, principal consultant - Automated IT Governance, Risk, Compliance, Verista looks at building a practical AI governance foundation in regulated industries.
Leica Biosystems announced the addition of two Paige digital pathology AI-enabled products from Tempus to its Aperio AI Store—a unified, interoperable digital pathology platform that provides multiple AI-powered applications in a single interface.
OGT, a provider of genomic research and diagnostic solutions has unveiled next-generation sequencing (NGS) automation capabilities across its SureSeq NGS portfolio, compatible with the Hamilton NGS STAR Line.
Tekpak Automation has increased production throughput by over 30% for a UK pharmaceutical manufacturer of transdermal patches, thanks to a robotic packaging system built around continuous machine vision, inspection and active tracking.
Phesi has launched a new Protocol Complexity analysis module within its AI-powered Trial Accelerator platform that lets sponsors identify and reduce protocol complexity before it drives up cost, timelines and execution risk.
The latest research from LogiPharma has revealed that AI and machine learning are top investment priorities for pharmaceutical supply chain leaders, with advanced data analytics following behind as a key priority for 73% of respondents.
Jason Bryant, general manager of AI platforms at ArisGlobal, and Samuel Wallis, head of case processing at Bristol Myers Squibb, argue that pharmacovigilance teams need a formal measure of trust in validated AI systems.
Emerson has announced PACEdge version 3.0, the latest advancement to its IIoT enablement software platform, helping to bring AI capabilities and frictionless application deployment to edge devices.
